Your browser doesn't support javascript.
loading
MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier.
Huang, Xiao; Fei, Yuxin; Qiu, Xiaoyu; Qian, Tiantian; Shang, Quanmei; Cui, Jinfeng; Song, Yutong; Sheng, Shurui; Xiao, Wenhan; Yu, Qilin; Wang, Tao; Wang, Xiaozhi.
Afiliação
  • Huang X; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Fei Y; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Qiu X; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China; Department of Pulmonary and Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
  • Qian T; Department of Respiratory Medicine, Ji'nan Zhangqiu District People's Hospital, No. 1920 Mingshuihuiquan Road, Ji'nan, 250200, Shandong, China.
  • Shang Q; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Cui J; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Song Y; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Sheng S; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Xiao W; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Yu Q; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
  • Wang T; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China. Electronic address: wtsjr@163.com.
  • Wang X; Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China. Electronic address: hxicuwxz@163.com.
Int Immunopharmacol ; 137: 112508, 2024 Aug 20.
Article em En | MEDLINE | ID: mdl-38889512
ABSTRACT

BACKGROUND:

MicroRNA plays an important role in the progression of sepsis. We found a significant increase of in miR-625-5p expression in the blood of patients with sepsis, and lipopolysaccharide (LPS)-stimulated EA.hy926 cells. To date, little is known about the specific biological function of miR-625-5p in sepsis.

METHODS:

Changes in miR-625-5p expression were verified through quantitative real-time polymerase chain reaction in 45 patients with sepsis or septic shock and 30 healthy subjects. In vitro, EA.hy926 cells were treated with LPS. Transendothelial electrical resistance assay and FITC-dextran were used in evaluating endothelial barrier function.

RESULTS:

Herein, patients with sepsis or septic shock had significantly higher miR-625-5p expression levels, chemokine (C-X-C motif) ligand 16 (CXCL16) levels, and glycocalyx components than the healthy controls, and miR-625-5p level was positively correlated with disease. Kaplan-Meier analysis demonstrated a strong association between miR-625-5p level and 28-day mortality. Furthermore, the miR-625-5p inhibitor significantly alleviated LPS-induced endothelial barrier injury in vitro. Then, miR-625-5p positively regulated CXCL16 and down-regulated miR-625-5p attenuated CXCL16 transcription and expression in EA.hy926 cells. CXCL16 knockout significantly alleviated vascular barrier dysfunction in the LPS-induced EA.hy926 cells. sCXCL16 treatment in EA.hy926 cells significantly increased endothelial hyperpermeability by disrupting endothelial glycocalyx, tight junction proteins, and adherens junction proteins through the modulation of C-X-C chemokine receptor type 6 (CXCR6).

CONCLUSIONS:

Increase in miR-625-5p level may be an effective biomarker for predicting 28-day mortality in patients with sepsis/septic shock. miR-625-5p is a critical pathogenic factor for endothelial barrier dysfunction in LPS-induced EA.hy926 cells because it activates the CXCL16/CXCR6 axis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Sepse / MicroRNAs / Quimiocina CXCL16 / Receptores CXCR6 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipopolissacarídeos / Sepse / MicroRNAs / Quimiocina CXCL16 / Receptores CXCR6 Idioma: En Ano de publicação: 2024 Tipo de documento: Article